Form 4: AtriCure Director Robert S. White Exercises Stock Options
SEC Form 4 Filing
Director Robert S. White exercised non-qualified stock options to acquire 10,000 shares of AtriCure, Inc. common stock at a price of $15.96 on February 23, 2024.
Summary
- On February 23, 2024, Robert S. White, a director of AtriCure, Inc., exercised non-qualified stock options.
- This transaction involved the acquisition of 10,000 shares of AtriCure common stock at a price of $15.96 per share.
- Following the transaction, White directly owns 88,985 shares of AtriCure common stock.
- The exercised options were granted on May 14, 2014, and vested over a period of four years.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Option exercises are a common way for executives and directors to realize compensation.
Key Dates
| Date | Description |
|---|---|
| 05/14/2014 | Date the non-qualified stock options were granted. |
| 05/14/2015 | First vesting date of the options (25%). |
| 02/23/2024 | Date of the transaction: exercise of stock options. |
| 02/27/2024 | Date of signature on the Form 4 filing. |
| 05/14/2024 | Expiration date of the non-qualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.